Management

Klaus Hellerbrand and Dr. Andreas Schütz

Klaus Hellerbrand (left) and Dr. Andreas Schütz (right), managing directors.

Andreas Schütz
Dr. Schütz studied Pharmacy and received his PhD in Pharmaceutical Technology from the University of Erlangen in 1991. He began his career in pharmaceutical development with Schwarz Pharma AG based in Monheim, Germany and last held the position of Head of Specialized Pharmaceutical Systems. Dr. Schütz joined Vetter Pharma, based in Ravensburg, Germany in 1998 as Head of Pharmaceutical Development and Senior Project Manager. In 2001, Dr. Schütz joined Scil Technology based in Munich, Germany and last held the position of VP Pharmaceutical Development and Head of BioPharma Services.Together with Klaus Hellerbrand he founded ProJect Pharmaceutics in 2010. Andreas Schütz is an inventor on numerous patents and patent applications. His key expertise is focused on Formulation Science, Drug Delivery Systems, Lyophilization Technology, Aseptic Processing, Project and Key Account Management

Klaus Hellerbrand
Klaus Hellerbrand earned his degree of applied Science in Biotechnology from the University of Weihenstephan. In 1995 he joined Boehringer Mannheim / Roche Diagnostics as a development engineer focused on down-stream processes for protein drugs and development of protein formulations. He joined Scil Technology in 1999 as protein formulation scientist. Serving in positions of increasing responsibility, in 2003 he became Head of Pharmaceutical Technology, responsible for product formulation and protein drug supply. Together with Andreas Schütz he founded ProJect Pharmaceutics in 2010. Klaus Hellerbrand is an inventor on numerous patents and patent applications. He is an expert in Protein Science, Protein Analytics, Downstream Processing, Process Technology, Coating Technology and Lyophilization Technology.

Print Friendly